An introduction of the Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) Project
Journal of Health Informatics and Statistics. 2021;46(4):369-377 
Project aims to advance vaccine benefit:risk assessment in Europe
Reactions Weekly. 2013;1482(1):2-2
Risk-benefit analysis of emergency vaccine use
Scientific Reports. 2022;12(1):
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine
Vaccine. 2023;41(15):2615-2629
The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG)
Vaccine. 2021;39(22):3050-3052
A risk–benefit analysis of vaccination
Vaccine. 2009;27:G9-G12
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)
Vaccine. 2022;40(35):5275-5293
Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct
Vaccine. 2018;36(2):194-195
Introduction
Cost-Benefit Analysis for Project Appraisal. 2015;1-8
WITHDRAWN: Dengue Human Infection Models to Advance Dengue Vaccine Development
Vaccine. 2015;